Royal Cambodian Armed Forces Report issue

Government

Organization Overview

First Clinical Trial
2012
NCT01624337
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (3)

artemisinin (2 trials)

piperaquinoline (2 trials)

primaquine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 3